Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pyoderma.

F C Powell, R K Winkelmann

    The British Journal of Dermatology
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Malignant pyoderma, a rare skin disease, presents as destructive ulcers in young adults. Successful treatment involves corticosteroids and cyclophosphamide, offering hope for managing this progressive condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of Demodex mite viability using motility and scattered light intensity.

    Experimental & applied acarology·2019
    Same author

    Enhancing survival of Demodex mites in vitro.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2018
    Same author

    Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea.

    The British journal of dermatology·2018
    Same author

    Study of Demodex mites: Challenges and Solutions.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2015
    Same author

    Understanding rosacea.

    The British journal of dermatology·2015
    Same author

    Epidermal hydration levels in patients with rosacea improve after minocycline therapy.

    The British journal of dermatology·2013
    Same journal

    Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

    The British journal of dermatology·2026
    Same journal

    Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

    The British journal of dermatology·2026
    Same journal

    Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

    The British journal of dermatology·2026
    Same journal

    EPHX3-nEDD: from molecular diagnosis to epidermal lipid biology.

    The British journal of dermatology·2026
    Same journal

    BAP1-tumour predisposition syndrome.

    The British journal of dermatology·2026
    Same journal

    Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

    The British journal of dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Immunodermatology
    • Rare Diseases

    Background:

    • Malignant pyoderma is a rare, chronic, destructive ulcerating skin disease of unknown etiology.
    • Typically affects young adults, predominantly males, with lesions often on the head and neck.
    • Previous cases suggest a progressive nature, sometimes associated with neurological disturbances.

    Observation:

    • This study details an additional case of malignant pyoderma.
    • It also provides a follow-up on a previously reported case.
    • Both cases highlight the clinical presentation and progression of the disease.

    Findings:

    • The disease is characterized by progressive, destructive ulcerating skin lesions.
    • Systemic corticosteroids are a known treatment modality.

    Related Experiment Videos

  • Combined therapy with corticosteroids and cyclophosphamide demonstrated successful management in a reported case.

    • Implications:

    • Corticosteroid and cyclophosphamide combination therapy offers a potential treatment strategy for malignant pyoderma.
    • Further research into the unknown cause of this rare dermatosis is warranted.
    • Understanding treatment outcomes can improve patient management and prognosis for this debilitating condition.